Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
Status:
Recruiting
Trial end date:
2030-12-30
Target enrollment:
Participant gender:
Summary
Primary end points:
This clinical trial is aimed to analyze the effectiveness of Levonorgestrel-Releasing
Intrauterine System (LNG-IUS, Mirena®) in the fertility-sparing treatment of atypical
endometrial hyperplasia and early endometrial carcinoma, including pathology response and
pregnancy outcome.
Second end points:
To analyze the appearances of side-effects.